Discovery of a pathway-selective platelet P2Y1R inverse agonist that suppresses inflammation while preserving hemostasis
Simon C. Pitchford, Kazi Sumaita Nahar, Dingxin Pan, Claudia M. Sisk, Taha Al‐Adhami, Kubra Ekinci, Richard Thomas Amison, Nupur Gargate, Anjana Saji, Edward J. Wills, Clive Peter Page, Graham Ladds, Khondaker Miraz Rahman
This paper designs a pathway-selective P2Y1R inverse agonist that suppresses inflammation without affecting hemostasis, demonstrating its functional selectivity in vitro and in vivo.
bioRxiv · Jun 24, 2026 · PreprintPharmacology & Toxicology